XNCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Xencor Inc (XNCR) is not a strong buy for a beginner investor with a long-term strategy at this time. The company is facing significant financial challenges, with declining revenue, net income, and EPS in the latest quarter. Analysts have downgraded the stock, citing a lack of near-term catalysts and execution risks. While technical indicators show some bullish trends, the lack of strong positive catalysts and the absence of Intellectia Proprietary Trading Signals suggest that holding off on a purchase is the better option for now.
The MACD histogram is positive at 0.0236, indicating bullish momentum, but it is contracting. RSI is neutral at 45.86, suggesting no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 12.658, R1: 13.192, S1: 12.123, R2: 13.523, S2: 11.792.
NULL identified. No recent news or significant positive developments. Technical indicators are mildly bullish, but not strongly so.
Analysts have downgraded the stock, citing a lack of near-term catalysts and execution risks. Financial performance in the latest quarter showed significant declines in revenue (-59.67% YoY), net income (-87.56% YoY), and EPS (-87.67% YoY). No recent congress trading data or influential figure activity.
In Q4 2025, revenue dropped to $28.24M (-59.67% YoY), net income dropped to -$6.65M (-87.56% YoY), and EPS dropped to -0.09 (-87.67% YoY). Gross margin remained stable at 100%.
JPMorgan downgraded Xencor to Neutral from Overweight with a price target of $13, down from $18, citing 2026 as an execution year with unclear catalysts. Barclays maintains an Overweight rating with a price target of $27, but this is based on a long-term model update rather than near-term performance.
